These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15451021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
    Langer I, Langlet C, Robberecht P.
    J Mol Endocrinol; 2005 Apr; 34(2):405-14. PubMed ID: 15821106
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J, Juarranz MG, Perret J, Bondue A, Solano RM, Delporte C, De Neef P, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
    Ceraudo E, Tan YV, Couvineau A, Lacapere JJ, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul; 1070():180-4. PubMed ID: 16888162
    [Abstract] [Full Text] [Related]

  • 10. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
    Du K, Nicole P, Couvineau A, Laburthe M.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):289-92. PubMed ID: 9016768
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
    Vertongen P, Solano RM, Perret J, Langer I, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2001 Aug 13; 133(8):1249-54. PubMed ID: 11498510
    [Abstract] [Full Text] [Related]

  • 12. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.
    J Neuroimmunol; 2005 Jan 13; 158(1-2):94-105. PubMed ID: 15589042
    [Abstract] [Full Text] [Related]

  • 13. A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
    Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P.
    Mol Endocrinol; 2002 May 13; 16(5):1089-96. PubMed ID: 11981043
    [Abstract] [Full Text] [Related]

  • 14. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 13; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
    Couvineau A, Rouyer-Fessard C, Laburthe M.
    Regul Pept; 2004 Dec 15; 123(1-3):181-5. PubMed ID: 15518910
    [Abstract] [Full Text] [Related]

  • 17. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
    El Zein N, Badran B, Sariban E.
    J Leukoc Biol; 2008 Apr 15; 83(4):972-81. PubMed ID: 18174366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways.
    Dickson L, Aramori I, Sharkey J, Finlayson K.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():239-42. PubMed ID: 16888173
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.